ArticleFrontiers in immunology2022
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Masashi Furukawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it